Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-07

Clinical Trial Update: Lenalidomide and Dexamethasone Versus Melphalan Prednisone and Lenalidomide Versus Cyclophosphamide, Prednisone and Lenalidomide in Elderly Multiple Myeloma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing three lenalidomide-based regimens in elderly multiple myeloma patients; lenalidomide+dexamethasone vs melphalan-prednisone+lenalidomide …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • DEXAMETHASONE (Dexamethasone)
  • Lenalidomide (lenalidomide)
  • Melphalan (Melphalan)
  • PREDNISONE (Prednisone)

Snippet

Sponsor: Fondazione EMN Italy Onlus | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED